<sup>18</sup>F-FDG PET as an imaging biomarker for the response to FGFR-targeted therapy of cancer cells via FGFR-initiated mTOR/HK2 axis
Yuchen Jiang(Shanghai Institute of Materia Medica), Ruimin Huang(University of Chinese Academy of Sciences)
Cited by 11
Related Papers
Modified citrus pectin inhibited bladder tumor growth through downregulation of galectin-3
|Acta Pharmacologica Sinica|2018|66
Pao Pereira extract suppresses benign prostatic hyperplasia by inhibiting inflammation-associated NFκB signaling
|BMC Complementary Medicine and Therapies|2020|11